While our industry has continued to raise awareness about the lack of diversity within clinical trials, actually addressing the issue remains our b...
.jpg)
In this episode of CM Conversations, our guest share his tips on hitting the ground running and building a team remotely, as well as the importance of investing in relationships. In his words, you should always be visible and available.
While our industry has continued to raise awareness about the lack of diversity within clinical trials, actually addressing the issue remains our biggest challenge. Click to read how some leaders are addressing this.
In this episode of CM Conversations, our guest share his tips on hitting the ground running and building a team remotely, as well as the importance of investing in relationships. In his words, you should always be visible and available.
.jpg)
In pharma packaging and drug delivery, everyone is beginning to talk about sustainability again. How can we meet this increasing demand without causing further harm to our environment? Click to read about 5 companies embracing change.
There are few areas of the healthcare space that are causing as much excitement, or have as much potential, as CRISPR.
.jpg)
In this live webinar, we asked three experienced commercial leaders about their insights, advice and predictions on the future of this market. Click to watch.
.jpg)
In this live webinar, I asked three experienced commercial leaders about their insights, advice and predictions on the future of lateral flow. Click to listen now.
Bioinformatics is transforming personalised care for cancer and rare diseases and aiding in novel drug discovery. In this article, I wanted to highlight the work and progress being made by some of the top companies in the space.
In the US, New Jersey is a life science powerhouse. It’s home to some of the most influential pharma manufacturers in the world. Click to find out some of the latest developments coming from this area.
In this episode of CM Conversation, I spoke to Miron Tokarski, CEO of Genomtec, a company operating in the field of clinical diagnostics. Also joining us was Magdalena Kicińska, Marketing Partner at Genomtec. Click to listen to the full episode.
I’d like to celebrate these hard-working people by acknowledging the technologies behind four of the most innovative start-ups disrupting blood-based diagnostics right now. Click to find out who they are.
.jpg)
Whether you've recently started a new job yourself, know someone who has, or are looking to optimise your company's onboarding process; this CM Conversations episode is for you. Click to listen.
I come across different exciting companies every day. Each has their own unique story and innovative treatments to match. Click for five companies who’s work you need to know about.
In this clip, I talk about how acting fast is crucial to securing the very best talent in life sciences.
.jpg)
In this clip, I discuss the skills and people that are in demand within the life science industry.
.jpg)
In this clip, I talk about how small companies can beat the larger corporations for talent. They just need to show off what makes them different, that they're people-focused and they can be flexible.
Everyone is talking about Seaspiracy and the environmental impact of commercial fishing. That’s great. This is an important environmental issue that people need to be aware of. But did the film fail to discuss something major?
Pharma packaging is embracing digital health to become smarter and safer. I wanted to highlight some of the exciting developments that are integrating the use of digital technology within the healthcare sectors and the companies involved.
Toxicology is such an exciting space to be working in right now, with the market continuing innovate. Within this article, I wanted to share just some of the innovative companies that I’ve seen help take toxicology to new heights.
POC diagnostics has played a crucial role in the fight against COVID-19. In this episode of CM Conversations, I speak to Jonathan O’Halloran, who is CEO at QuantuMDx and an industry expert. I ask him: What's next for POC diagnostics?
In this live episode, join life science recruitment experts Eleanor Doolin and Adam Butler as they discuss how the best businesses from across the life science space are winning the war for talent.
Special purpose acquisition companies, or SPACs, have recently emerged onto the investment scene at a rapid rate. They are an unconventional means of taking a company public but becoming increasingly popular. Are SPACs really here to stay?
Every industry ground to a halt in March 2020 as COVID-19 swept the world. While some sectors were forced to shut down completely, clinical trial providers couldn’t simply stop. That would have meant years of research and funding gone to waste.
We're not talking about 'using Zoom' - everyone's mastered that in the last 12 months. Instead, we discuss how to optimise the virtual hiring process to ensure you get the most out of it.
.jpg)
Diagnostics still has a crucial role to play in combating COVID-19 and, with new funding, a lot of exciting plans too. To find out more, I spoke to Jonathan O’Halloran, who is CEO at QuantuMDx.
What do you want from diagnostics? Before COVID-19, this wouldn’t have been a question at the forefront of so many peoples' minds. However, now it is and consumers are demanding changes to the industry.
I've collaborated with multiple experts at major small molecule CDMOs to talk about the impact that biologics has has on their industry. This article featured in the industry leading publication, Speciality Chemicals Magazine.
Demand for biologics is at an all-time high, which has forced businesses to majorly invest in manufacturing and production.
Innovative companies are trying to make a real difference for patients with rare diseases and address one of healthcare's largest unmet needs.
.jpg)
There’s optimism throughout all the markets we serve and to celebrate this we asked our CM Life Science team what they think we can expect from the year ahead in life sciences. Here's what they said...
